Last reviewed · How we verify

NCT06171763

The Multi-stakeholder Assessment of Economic and Managerial Determinants and Impacts of Telemedicine

Completed NA Last updated 20 December 2023
What this trial tests

NA trial testing Telemedicine in Telemedicine in 150 participants. Completed in 8 November 2023.

Timeline
8 August 2022
Primary endpoint
30 September 2023
8 November 2023

Quick facts

Lead sponsorBuzzi Children's Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment150
Start date8 August 2022
Primary completion30 September 2023
Estimated completion8 November 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Buzzi Children's Hospital

Who can join

Adults 12 Months to 18, any sex, with Telemedicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to conduct a comprehensive evaluation involving multiple stakeholders to assess the factors influencing and the consequences of telehomecare in comparison to traditional care models. The integration of technology into the healthcare sector necessitates significant changes in care of patients, organizational structures, production processes, organizational responsibilities, and the management of service delivery processes. The delivery of telemedicine services through integrated devices represents a method of service production that demands active involvement from patients or, in the case of pediatric patients, their caregivers. This collaborative process of patient engagement in healthcare services is referred to as "co-production." In this research, telehomecare will be examined as an illustrative instance of co-producing healthcare services. Co-production implies that the inputs into a production process are contributed not only by the organization producing a good or service but also by the users. In the case study, co-production occurs through the interaction between patients/caregivers and professionals during telehealth visits for device-mediated monitoring activities. Throughout the televisit, patients/caregivers play a crucial role in collecting and sharing the necessary parameters with professionals using the device, thereby serving as essential actors in the care process. The investigators explored the impact of a transitional care program, utilizing an user-friendly mobile medical device, to support an early discharges in a pediatric setting. Clinical outcome and economic advantages are considered. This study will contribute to implement knowledge on the role of telemedicine on HaH healthcare in pediatrics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Leveraging User-Friendly Mobile Medical Devices to Facilitate Early Hospital Discharges in a Pediatric Setting: A Randomized Trial Study Protocol
    Zuccotti G, Marsilio M, Fiori L, Erba P, et al · · 2024

Verify or expand the search:

Other trials of Telemedicine

Trials testing the same drug.

Other recruiting trials for Telemedicine

Currently open trials in the same condition.

Other Buzzi Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing